Israel is eighth in the number of patents granted in the life-sciences industry, which may be the most amazing statistic of all, given the amount of time and money companies must invest in getting a product or technology tested and patented.

This week, the Israeli biotech industry was having its annual conference, the Biomed Israel 2011 show, sponsored by the Life Sciences Industries Association in Israel (ILSI), a nonprofit organization founded to serve and promote the goals of the Israeli life-sciences industry in the international arena. The show, which is taking place in Tel Aviv and is celebrating its tenth anniversary, has become a can’t-miss affair for top executives of pharmaceutical and medical-technology giants around the world.

So how successful has the Israeli life sciences industry been? Check out the stats: There are currently about 700 active life-sciences companies in Israel; 56 percent of them (396) of them were founded in the last decade.

A quarter of them, 173, were founded only five years ago. Of the rest, 306 were founded before 2001, with the oldest, Teva Pharmaceuticals, founded in 1901 (amazing but true). Out of the 700, 401 (56%) are in the medicaldevices business.

From 2001 to 2005 the industry’s annual growth was 12%. Even though things have slowed a bit over the past three years, Biomed organizing committee chairperson Ruti Alon says growth has returned to the sector.

More than 100 of the companies established over the last decade are making money, she says, and “the most impressive fact is that 25 companies, about 8% of all companies that produce income, were founded only five years ago.”

Some testimonials as for ILSI- Biomed Israel 2011:

“Back to Paris I would like to thank you for the excellence of the organization and the quality of the Company we have met. We learned a lot and see several opportunities to partner with Israeli Biotech Companies”

- Philippe Goupit, Sanofi-Aventis, Business Development Corporate Licenses

“I would like to thank you very much for giving me the opportunity to talk about EU reimbursement during ILSI Biomed in Tel Aviv. I was impressed by the fantastic organization of the program and the conference itself.
It would be a very great pleasure for me to participate again next year”

- Dr. Hubertus Rosery MPH (CEO), AiM GmbH, Assessment in Medicine Research and Consulting

“Thanks for the nice introduction; I had a number of meetings and feel that I am slowly getting to know the needs and interests of the many wonderful technology companies born in Israel. Congratulations on a very successful conference!”

- Dan Mendelson, CEO, Avalere Health LLC

Really excellent. Well planned. Very nice atmosphere.
Key-note speakers were the best. Cocktail party was a delight.
Kenes did a great job. Kol Hakavod to ILSI & Ruti.

- David Blum

Tweet

Share on Facebook

This is a Call for a Change – Don’t Miss the Opportunity to Present and to Win at the upcoming 2011 ILSI – BioMed Conferenc.

Once again, BioJerusalem is delighted to hold the ‘Start Up’s Pavilion’, offering start-up companies the opportunity to showcase their technologies and products. In addition, this year they offer start ups, for the first time, increased exposure with the opportunity to present your company as part of the Conference’s main program which takes place at the David InterContinental Hotel.

The Start Up’s Pavilion is offering bio and medical devices company managers an opportunity to:

Showcase your technology/product in a special exhibit area
Present your company during the ILSI-Biomed 2011 Conference program (‘elevator speech presentation’)
Be awarded for your presentation.

Make a wise decision – Join those already registered!

The Start-Up Competition

All start-up exhibitors will be entitled to present their company as part of the prize-bearing “Start-Up Competition”. The audience and a panel of distinguished international industry leaders will choose the most promising medical device company & and best biotech company. Each company will be allotted a 3-minute presentation, out of which, few finalists will be selected and have a chance to deliver a full company presentation. The winners of the ILSI Biomed 2011 most promising start-ups will be announced in a prize awarding ceremony!

What “Start Up” participants are offered:

* Opportunity to introduce your company to a panel of international industry leaders, including senior industry executives and venture capitalists
* Maximum exposure to leading industry players, creating new business opportunities
* Interaction with international delegations and thousands of visitors from Israel & worldwide
* Pre-set private one-on-one meetings scheduled via our networking engine, providing the opportunity for new partnerships with industry and investors
* Exposure in the conference’s official website and publications
* The ‘Start Up Pavilion’ is located adjacent to the ‘Networking Pavilion’ at the Dan Panorama Hotel, where the partnering meetings, one of the conference’s attractions, takes place.

Technical specifications of branded start-up stand:

A display of 4.5 sqm (3X1.5)
Meeting table & two chairs
Electricity outlet
Branded attendant desk
Signage
Participation cost:

A nominal fee of 2,300 NIS + VAT

www.kenes.com/biomed

Tweet

Share on Facebook

10 more years!

May 23-25 2011. ILSI-BioMed Israel 2011, that is.

The 10th international Life Science & Technology Week is just around the corner. The event follows the highly successful 2010 BioMed conference which attracted more than 6000 participants from 51 countries.

LSI-BioMed 2011 will present high-quality program, featuring top-notch industry executives. Israel’s most innovative medical device and BioPharma entrepreneurs, major pharmaceutical companies, life science research leaders, policy makers and internationally prominent industry investors and the 4th international Stem Cell meeting.

Get ready!

ILSI-BioMed week – program at a glance.

Tweet

Share on Facebook

Panel discussions in 2011 will include:

Social Advertising
eTail, eCommerce, eIsrael
Cool Content and Convergence
Mobile Connections
Creative Consumer Products
From Seeding Ideas to Selling Shares
Breakthrough Medical Technology

Who: The Israel Conference™ features leaders of significant businesses that are Israel-facing that were founded in Israel, have R&D operations in Israel, do business in Israel, or represent investors in Israeli companies. Speakers represent the spirit of the inventiveness of the Israel market.

Why: By attending, you will meet with top minds of the movers and shakers from publicly traded companies, privately-held middle market firms, and early stage ventures along with private equity and venture investors. You will meet first-hand with the innovators of leading technologies from Israel that are market-making and in demand with the most forward-thinking technology and products in the world. Attendees gain an insider’s understanding of the growth of dynamic Israel-facing companies.

When: The Israel Conference™ 2011 will take place on Thursday June 2, 2011 in Los Angeles.

For more information: http://www.theisraelconference.com/index.php

Tweet

Share on Facebook

1st Prize: Up to $55,000(*) worth professional services.

The fourth annual competition is organized by Shizim in co-operation with The Israel Export and International Co-operation Institute and the 23rd Conference of the Society for Medical Innovation and Technology (SMIT), and the following business sponsors:

GCP Clinical Studies – Israel’s leading CRO;
Asis Enterprises – the leading business development company for penetrating Japan;
Dr. Eyal Bressler & Co. – leading Israeli intellectual property firm;
Eytan Liraz & Co. – leading Israeli law offices;
Aran Research Development & Prototypes – leading in product development services from idea to final product and production;
Sunrise Projects – the leading R&D granting consultancy in Israel;
Princeton Reimbursement Group (PRG) – the leading US Reimbursement company;
Signal Business Development (of Trendlines Group) – leading international marketing and business development firm;
The best company will win a prize worth up to $55,000* professional service package by the leading service providers:

Full patent application draft service, worth $7,500, provided by Dr. Eyal Bressler & Co.
Up to $7,500 worth of services for Product Development, provided by Aran Research Development & Prototypes.
Up to $7,500 worth of services for Management of Clinical Study in Israel, provided by GCP Clinical Studies.
Up to $7,500 worth of services for Business Development in Japan, provided by Asis Enterprises.
Up to $7,500 worth of Legal Services, provided by Eytan Liraz & Co. Law Offices.
Up to $7,500 worth of services for R&D Granting Consultation, provided by Sunrise Projects.
US Snapshot Reimbursement Assessment service, worth up to $5,000, provided by Princeton Reimbursement Group (PRG).
Up to $5,000 worth of services for Business Development, provided by Signal Business Development.

In addition, the top 3 winners will be offered to make a presentation at the international SMIT conference (www.smit2011.org).

Competition Stages:

Initial Participation Questionnaire: Fill-in a short (2 page) questionnaire, describing the company and the product. Filled-in questionnaires should be sent to the following address: yuval@shizim.com

Deadline for submitting the questionnaire: June 15th 2011.

Additional Info submission: The top 15 applicants will be requested to send additional information (e.g. presentations or business plans, etc.). All projects will be ranked by the judging panel that is comprised of the competition business partners and sponsors.

Top Ten Presentation Day – September 5th 2011: The top 10 ranked companies will be invited to hold a 20 minutes presentation to the judging panel members on September 6, 2011.

Winner Announcement: The winners will be announced during SMIT conference in Tel-Aviv, between September 14-16, 2011 (the exact announcement date will be decided and published in the agenda of the SMIT conference).

For further details contact Yuval at +972-3-900-2047 | yuval@shizim.com

Tweet

Share on Facebook

Location and dates: Tel Aviv, Jaffa, Israel
May 16 – 20, 2011

Venue: Renaissance Tel-Aviv 5*

Structure of the Symposium:
- plenary sessions
- sessions focused to individual topics
- round table discussions

Special emphasis will also be placed on informal discussions and there will be ample opportunity to meet and exchange views outside the lecture rooms.

Languages of the Symposium: English and Russian

Deadline for submission of abstracts: Last day for submission of abstracts to be considered for oral presentations is March 24, 2011.

ORGANIZERS

Pushchino Research Center of Russian Academy of Sciences, RF
Experimental Biotechnology Plant of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences EBP IBCH RAS, RF
R-PHARM, RF
The academy of Fine Chemical Technology named after M.V.Lomonosov, RF
GH BioQuenta Consulting e.U., Austria
Pharmbiotech- Invest Ltd., RF
ORGANIZING COMMITTEE

A. I. Miroshnikov, Dr.Sci., Member of Russ. Acad. Sci., RF – Chairman
D. I. Bairamashvili, Dr.Sci, RF
G. Halát, PhD., Austria
V. I. Shvets, Dr.Sci., Member of Russ. Acad. Med. Sci., RF

Tweet

Share on Facebook

The US/Israel Venture Summit, presented by youngStartup Ventures, is the premier gathering where cutting-edge Israeli startups meet top venture capitalists, angel investors, Corporate VCs and investment bankers from throughout North America. See http://www.youngstartup.com/usisrael2011/overview.php.

The JSBarkats’ team offers Israeli startups and their U.S. business partners a unique one stop shop for all their legal support needs, including Corporate, Securities, Life Sciences, Intellectual Property, and Israeli practice groups. Unlike many “Israeli practice groups” found in New York based firms, our Israeli practice group includes attorneys who are fluent in Hebrew, licensed to practice law in Israel and in New York, and knowledgeable in the practice of Israeli corporate and securities law. In addition, our attorneys are highly experienced practitioners in U.S. corporate, IP, banking and securities law, M&A, as well as other areas of practice, including real estate, immigration, taxation and trusts and estates. All of our firms’ practice groups work closely with one another to provide full support and added value to our clients. We look forward to meeting you at the summit.

About JSBarkats PLLC (www.JSBarkats.com)JSBarkats is a dynamic growing full-service law firm headquartered in the heart of Manhattan, NY. The firm provides experienced, efficient, and cost-effective legal services to institutional as well as small and mid-sized corporate clients and wealthy individuals. JSBarkats PLLC was founded on the principle that “Cold Blooded Billing” at inflated hourly rates is fundamentally unfair to clients and does not allow for proper monitoring of overall legal costs. Based on this premise, we offer a full range of legal services, on a FLAT FEE and milestone basis. This allows us to focus on the quality, rather than the quantity of our work, and enables our clients to quantify legal costs as part of their bottom line. www.JSBarkats.com

Tweet

Share on Facebook

Prof. Karin, from the University of California, San Diego, will receive the prize in the field of human health. He discovered the strong link between obesity, inflammation and cancer. The judges decided to award the prize to Prof. Karin for “his pioneering contribution that led to deciphering the molecular mechanism through which mammalian cells react to cytokines which cause inflammation, to adverse environmental conditions and also to various pathogens. His research laid the foundations for our understanding of the control mechanisms of transcription factor activities influenced by external stimulations, especially the transcription factors of the AP-1 family and NF-B. These discoveries led to the identification of new target protein cells that have recently been used to develop new medications for preventing and treating various malignant tumors.”

Prof. Polyakov, from Princeton University, will receive the prize in the field of science and technology. “He developed revolutionary theories that shaped our contemporary understanding of elementary particles in nature. In addition, he significantly contributed to condensed matter physics, statistical mechanics and mathematics. Among the ideas credited to him are topological structures (such as magnetic monopoles) in gauge field theories, which are important in understanding the confinement of quarks in the nucleus.
Polyakov also contributed to the foundations of string theory, the unification of quantum mechanics and gravity, and to the idea of duality between string theory and gauge field theory.”

The Technion’s prestigious Harvey Prize foresaw the winning of the Nobel Prize for two of the latest Nobel laureates – Elizabeth Blackburn (Medicine) and Ada Yonath of the Weizmann Institute of Science (Chemistry). To date, 13 Harvey Prize winners have gone on to win the Nobel Prize.

The Harvey Prize was first awarded in 1972 from a fund established by the late Leo M. Harvey of Los Angeles in order to recognize those who have made great contributions to advancing humanity in science and technology and in human health, as well as advancing peace in the Middle East. Every year, prizes totaling $75,000 per winner are awarded from the fund’s income.

Among the winners of the prestigious Harvey Prize are scientists from the US, Great Britain, Russia, Sweden, France and Israel. These include Nobel Prize laureate Mikhail Gorbachev, former leader of the USSR, who was awarded the prize for his activities aimed at reducing regional tensions; Prof. Bert Sakmann who won the Nobel Prize in Medicine; Prof. Pierre-Gilles de Gennes who won the Nobel Prize in Physics; Prof. Edward Teller for his discoveries in solid state physics, atomic physics and nuclear physics; and Prof. William J. Kolff for his invention of the artificial kidney.

Proposals for candidates for the Harvey Prize are received from leading scientists and personalities in Israel and the world. The prize laureates are chosen by the Harvey Prize committee in a stringent process at the Technion.

Tweet

Share on Facebook

If you are a representative of an biomed start-up company, you have the invitation to participate in ILSI-Biomed 2011 Conference to be held May 23-25, 2010 in Tel-Aviv. The conference is a meeting place for industry and academia from Israel and abroad. Exuberance is felt everywhere: lectures and exhibition halls and partnership meetings. International visitors come to hear about and witness the various innovations, and experience first hand the entrepreneurial spirit so strongly exhibited within the vibrant Israeli life science community.

ILSI-Biomed 2011 follows the success of previous annual conferences: last year’s event drew 6,000 industry players, engineers and scientists, with 1,000 participants from 42 countries and in excess of 2,500 one-on-one meetings.
Following the positive reaction from ILSI-BioMed 2010, we are delighted to incorporate the ‘Start Ups Pavilion’ into this year’s conference once again, giving Start-Ups the opportunity to showcase their technology/product.

In addition, all Start-Up exhibitors will be entitled to a short limited elevator speech, which will be part of the ILSI-Biomed 2011 Conference program. This session will be held at the David InterContinental Hotel. Presenting authors must hold one of the following positions: Chairman of the BOD, CEO, CFO, COO, CSO, VP of Business Development, VP of R&D, General Manager. At the end of the presentations an interactive round of voting will be done by the audience for the best companies. Prizes will be awarded to winning presentations! An added unique opportunity for participating Start-Ups, as venture capitalists and angel investors are very much present at the event.

The ‘Start Ups Pavilion’ will be set side by side with the ‘Networking Pavilion’ located at the Dan Panorama Hotel, where the executive meetings will take place, and will be presented as one of the main ILSI-Biomed 2011 attractions.

Definition of Start-Up companies:

- Limited operating history / generally newly created
- In a phase of development and research for market
- Annual revenue cycle should be below 500,000 USD.

What will the “Start Up” participants get?

An international encounter with team players, maximum exposure, creating new business opportunities with representatives of technology industries.
Interacting with international delegations and thousands of visitors from Israel & abroad.
Pre-set private one on one meetings scheduled via the Networking engine; providing the opportunity of creating new partnerships with potential clients/investors.
Targeted exposure of Start-Ups presenting at the ‘Start Ups Pavilion’ on the official ILSI-Biomed 2011 website and in publications.

Please note:
Space (exhibition and presentations) is limited and will be allotted on a ‘first come first serve’ basis.
Only exhibiting start-ups are permitted the elevator speech.

For further in formation please visit the official site.

Tweet

Share on Facebook

The goal of the meeting is to bring together cutting-edge scientists from the neurodegenerative diseases, and to focus on the enigma of inflammation in ALS.

Inflammation is one of the hallmarks characteristic of neurodegenerative diseases, yet targeting it has yielded inconsistent, conflicting data and even fatal clinical outcomes.

This conference will focus on this emerging aspect of neurodegenerative diseases, in general, and on ALS, in particular.
Such a forum will promote discussion to identify similarities and differences between ALS, Alzheimer’s disease, and Multiple Sclerosis that might shed light on the immunological and other factors responsible for the rapid progression of ALS.

With the support of the ISF and The Legacy Heritage Fund, this year the conference will have leading researchers from around the world that will cover different angles and aspects of the inflammation in neurodegenerative diseases.

More information at http://www.israls.org.il/kenes2011/index.html.

Tweet

Share on Facebook